COLONIE — Capital Region providers and agencies who deal directly with the opioid crisis every day have major concerns about the quality and length of local treatment programs for people battling addiction, according to a new Siena College survey.

The survey of more than 600 professionals in the medical, mental health, social service, nonprofit and law enforcement fields found that a majority believe treatment programs aren't working with addicted individuals long enough and blame insurance companies for refusing to cover comprehensive, adequate treatment.

"As bad as the public thinks this epidemic is, stakeholders know it's worse," said Don Levy, director of the Siena College Research Institute.

Eighty-eight percent of the professionals who were surveyed said the epidemic of opioid-related overdose deaths has gotten worse in recent years, and more than half expect it to continue to get worse.

National data support that conclusion. Drug overdose deaths in the U.S. have more than tripled since 1999, climbing steadily over the years and then accelerating around 2012, when it's believed a crackdown on prescription opioids fueled an illicit market for heroin and fentanyl. In 2016, nearly 64,000 Americans died of drug overdoses. Two-thirds were linked to opioids.

A major area of concern centers around treatment. A majority of survey-takers (55 percent) said they believe a person with an opioid addiction needs more than six months of treatment in order to recover successfully.

While the six-month mark is not a "magic number" for everyone, Dr. Melissa Weimer, an addiction medicine specialist at St. Peter's Health Partners, said that milestone is supported by scientific research into the effects on the brain of drug abuse, addiction and withdrawal.

Repeated drug use hijacks the brain's reward center. Imaging and mapping of the brain after drug use stops has shown that it takes about three months for the reward center to start returning to normal and about six months for it to return to baseline.

"The scary thing about opioids is that once you make it through acute withdrawal, unfortunately there's a stage called post-acute withdrawal that can actually last six months to a year — particularly if you're a person who has been using for a very long time," Weimer said.

The symptoms are mild compared to acute withdrawal, she said, but frequently contribute to relapse.

"It is often felt as kind of a low-lying, constant anxiety," said Weimer. "So you have this continual sense of anxiety and irritability. If you undergo a major stress or have underlying anxiety or depression to begin with it can be a strong relapse trigger."

There is medicine to lessen these symptoms, she said. A doctor might prescribe selective serotonin reuptake inhibitors (SSRIs) or non-habit forming clonidine or hydroxyzine.

So why aren't people getting the treatment they need? Or, if they are, why isn't it successful?

The Siena survey revealed some theories. While a majority of local professionals say most treatment programs in the area are "somewhat" effective at getting patients to overcome addiction, 64 percent say treatment just isn't long enough and identified insurance refusing to cover adequate treatment as a major issue locally.

Almost all of those surveyed say insurers should be required to cover treatment beyond the initial detox period, which Weimer said can take three to 14 days depending on how long somebody used opioids and the type of opioid used. The process can be shortened with medications such as buprenorphine, methadone, clonidine or hydroxyzine, she said.

Local health insurers say they follow rules prescribed by the state Office of Alcoholism and Substance Abuse Services when it comes to covering addiction treatment.

Using a tool known as LOCADTR (Level of Care for Alcohol and Drug Treatment Referral), providers and insurers assess a patient's treatment history, medical and psychiatric background, risk factors and social supports to identify which level of care and treatment setting is most appropriate, safe and effective.

"Every health plan is different," said Dr. Kirk Panneton, vice president and regional executive and medical director for BlueShield of Northeastern New York, which offers plans in the Albany area. "But I think there's no question that there's more coverage now, especially given the concerns these past couple years showing this is an epidemic both locally and nationally."

That may be true, advocates say, but there's no doubt that insurers continue to offer inadequate coverage to individuals with mental health and substance abuse issues. Although state and national parity laws require insurers to provide mental health and substance abuse benefits on par with medical and surgical benefits, not everyone complies.

Since 2014, the New York attorney general's office has reached settlements with at least five insurers, including MVP Health Care in Schenectady, after finding they had violated parity laws.

State lawmakers this week passed legislation requiring insurers to submit annual reports to the state Department of Financial Services outlining their compliance with parity laws. The bill still needs the governor's signature.

"These laws have been on the books for decades now, but we're still seeing disparities," said Stephanie Campbell, executive director of Friends of Recovery-New York, a group that advocates for people in recovery from substance abuse.

People seeking mental health and substance abuse treatment have been subjected to higher specialist co-payments, she said, and are more likely to be denied coverage for inpatient treatment under the guise that it's "not medically necessary," she said.

Not everyone needs inpatient services — someone with a steady job, car, friends and family support system, for example, is better suited for outpatient treatment, Weimer said. Those who lack stable housing, income, transportation and social support systems, however, benefit greatly from intensive, inpatient rehabilitation, she said.

If cost of lengthy or intensive treatment programs is the concern among insurers, Campbell suggests they consider the costs of not providing adequate treatment.

"When you can recover and reintegrate into society, you get a job, you pay taxes, your hospitalizations go down, your arrests go down," she said. "The cost-benefit of treating addiction like any other chronic illness is really overwhelming."

See the full Siena College survey here.